Mitomycin C after photorefractive keratectomy (PRK) is used to reduce the development of haze and regression in higher intended corrections. The aim of this study was to investigate the safety, stability, and efficacy of EpiLASIK with mitomycin C.
Methods
Fifty eyes of 29 patients underwent EpiLASIK with the Gebauer EpiLift microkeratome. The mean preoperative spherical equivalent was −6.89 D (SD ±0.63, range −6.0 to −8.0 D). After the laser ablation, mitomycin C 0.02% was applied for 30 seconds on a sterile filter paper. Preoperatively and 1, 3, 6, and 12 months after surgery, a full ophthalmic examination was performed.
Results
In 42 of 50 eyes, the bandage contact lens was removed at day 3. Twelve months after surgery, 96% of all eyes were within ±1.0 D and 82% were within ±0.5 D of intended correction. Five percent of all patients lost 1 line of best-corrected Snellen visual acuity, 42% were stable, and 56% gained 1 or more lines. In most patients, the cornea was clear during the whole follow-up, and in 10% only trace haze was visible. The uncorrected visual acuity was at least 1.0 in 86% of all patients, and all patients reached 0.5.
Conclusions
EpiLASIK with mitomycin C with higher intended corrections seems to be an effective and safe procedure. With the application of mitomycin C, only minimal haze appears.
TrokelS.L., SrinivasanR., BrarenB.Excimer laser surgery of the cornea. Am J Ophthalmol1983; 96: 710–5.
2.
AmbrosioR.Jr., WilsonS.LASIK vs LASEK vs PRK: advantages and indications. Semin Ophthalmol2003; 18: 2–10.
3.
FernandezA.P., JaramilloJ., JaramilloM.Comparison of photorefractive keratectomy and laser in situ keratomileusis for myopia of –6 d or less using the Nidek EC-5000 laser. J Refract Surg2000; 16: 711–5.
4.
PallikarisI.G., SiganosD.S.Excimer laser in situ keratomileusis and photorefractive keratectomy for correction of high myopia. J Refract Corneal Surg1994; 10: 498–510.
5.
PopM., PayetteY.Photorefractive keratectomy versus laser in situ keratomileusis: a control-matched study. Ophthalmology2000; 107: 251–7.
6.
SugarA., RapuanoC.J., CulbertsonW.W.. Laser in situ keratomileusis for myopia and astigmatism: safety and efficacy: a report by the American Academy of Ophthalmology. Ophthalmology2002; 109: 175–87.
7.
BedeiA., MarabottiA., GiannecchiniI.. Photorefractive keratectomy in high myopic defects with or without intraoperative mitomycin C: 1-year results. Eur J Ophthalmol2006; 16: 229–34.
8.
GambatoC., GhirlandoA., MorettoE., BusatoF., MidenaE.Mitomycin C modulation of corneal wound healing after photorefractive keratectomy in highly myopic eyes. Ophthalmology2005; 112: 208–18; discussion 219.
9.
LohmannC.P., PatmoreA., O'BrartD., ReischlU., Winkler MohrenfelsC., MarshallJ.Regression and wound healing after excimer laser PRK: a histopathological study on human corneas. Eur J Ophthalmol1997; 7: 130–8.
10.
MohanR.R., HutcheonA.E., ChoiR.. Apoptosis, necrosis, proliferation, and myofibroblast generation in the stroma following LASIK and PRK. Exp Eye Res2003; 76: 71–87.
11.
WilsonS.E.Role of apoptosis in wound healing in the cornea. Cornea2000; 19: S7–12.
12.
WilsonS.E., KimW.J.Keratocyte apoptosis: implications on corneal wound healing, tissue organization, and disease. Invest Ophthalmol Vis Sci1998; 39: 220–6.
13.
WilsonS.E., MohanR.R., AmbrosioR.Corneal injury. A relatively pure model of stromal-epithelial interactions in wound healing. Methods Mol Med2003; 78: 67–81.
14.
WilsonS.E., MohanR.R., AmbrosioR.Jr., HongJ., LeeJ.The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog Retin Eye Res2001; 20: 625–37.
15.
WilsonS.E., MohanR.R., HongJ., LeeJ., ChoiR., LiuJ.J.Apoptosis in the cornea in response to epithelial injury: significance to wound healing and dry eye. Adv Exp Med Biol2002; 506: 821–6.
16.
Baldwin HeM.J.Growth factors in corneal wound healing following refractive surgery: a review. Acta Ophthalmol Scand2002; 80: 238–47. Review.
17.
AndersonN.J., BeranR.F., SchneiderT.L.Epi-LASEK for the correction of myopia and myopic astigmatism. J Cataract Refract Surg2002; 28: 1343–7.
18.
FagerholmP., Hamberg-NystromH., TengrothB.Wound healing and myopic regression following photorefractive keratectomy. Acta Ophthalmol (Copenh)1994; 72: 229–34.
19.
LeeJ.B., ChoeC.M., KimH.S., SeoK.Y., SeongG.J., KimE.K.Comparison of tgf-beta1 in tears following laser subepithelial keratomileusis and photorefractive keratectomy. J Refract Surg2002; 18: 130–4.
20.
LeeJ.B., SeongG.J., LeeJ.H., SeoK.Y., LeeY.G., KimE.K.Comparison of laser epithelial keratomileusis and photorefractive keratectomy for low to moderate myopia. J Cataract Refract Surg2001; 27: 565–70.
21.
NakamuraK., KurosakaD., Bissen-MiyajimaH., TsubotaK.Intact corneal epithelium is essential for the prevention of stromal haze after laser assisted in situ keratomileusis. Br J Ophthalmol2001; 85: 209–13.
22.
PallikarisI.G., NaoumidiI.I., KalyvianakiM.I., KatsanevakiV.J.Epi-LASIK: comparative histological evaluation of mechanical and alcohol-assisted epithelial separation. J Cataract Refract Surg2003; 29: 1496–501.
23.
KatsanevakiV.J., NaoumidiI.I., KalyvianakiM.I., PallikarisG.Epi-LASIK: histological findings of separated epithelial sheets 24 hours after treatment. J Refract Surg2006; 22: 151–4.
24.
LongQ., ChuR., ZhouX., DaiJ., ChenC., RaoS.K., LamD.S.Correlation between tgf-beta1 in tears and corneal haze following LASEK and epi-LASIK. J Refract Surg2006; 22: 708–12.
25.
NettoM.V., MohanR.R., SinhaS., SharmaA., GuptaP.C., WilsonS.E.Effect of prophylactic and therapeutic mitomycin C on corneal apoptosis, cellular proliferation, haze, and long-term keratocyte density in rabbits. J Refract Surg2006; 22: 562–74.
26.
Winkler von MohrenfelsC., HermannW., GablerB., MullerM., MarshallJ., LohmannC.P.Topisches mitomycin C zur behandlung von haze nach excimer laser photorefraktiver keratektomie (PRK). Klin Monatsbl Augenheilkd2001; 218: 763–7.
27.
FantesF.E., HannaK.D., WaringG.O.III, PouliquenY., ThompsonK.P., SavoldelliM.Wound healing after excimer laser keratomileusis (photorefractive keratectomy) in monkeys. Arch Ophthalmol1990; 108: 665–75.
28.
KalyvianakiM.I., KymionisG.D., KounisG.A., PanagopoulouS.I., GrentzelosM.A., PallikarisI.G.Comparison of epi-LASIK and off-flap epi-LASIK for the treatment of low and moderate myopia. Ophthalmology2008; 115: 2174–80.
29.
KatsanevakiV.J., KalyvianakiM.I., KavroulakiD.S., PallikarisI.G.One-year clinical results after epi-LASIK for myopia. Ophthalmology2007; 114: 1111–7.
30.
PallikarisI.G., KalyvianakiM.I., KatsanevakiV.J., GinisH.S.Epi-LASIK: preliminary clinical results of an alternative surface ablation procedure. J Cataract Refract Surg2005; 31: 879–85.
31.
LacayoG.O.3rd, MajmudarP.A.How and when to use mitomycin-C in refractive surgery. Curr Opin Ophthalmol2005; 16: 256–9.
32.
ThorntonI., PuriA., XuM., KruegerR.R.Low-dose mitomycin C as a prophylaxis for corneal haze in myopic surface ablation. Am J Ophthalmol2007; 144: 673–81.
33.
de Benito-LlopisL., TeusM.A., Sanchez-PinaJ.M.Comparison between LASEK with mitomycin C and LASIK for the correction of myopia of −7.00 to −13.75 D. J Refract Surg2008; 24: 516–23.
34.
CamellinM.Laser epithelial keratomileusis with mitomycin C: indications and limits. J Refract Surg2004; 20: S693–8.
35.
ArgentoC., CosentinoM.J., GanlyM.Comparison of laser epithelial keratomileusis with and without the use of mitomycin C. J Refract Surg2006; 22: 782–6.
36.
de Benito-LlopisL., TeusM.A., OrtegaM.Effect of mitomycin-C on the corneal endothelium during excimer laser surface ablation. J Cataract Refract Surg2007; 33: 1009–13.
37.
TeusM.A., de Benito-LlopisL.Laser-assisted subepithelial keratectomy with MMC to treat post-LASIK myopic regression. J Cataract Refract Surg2007; 33: 1674–5; author reply 1675–6.
38.
NakanoE.M., BainsH.S., HiraiF.E., PortellinhaW., OliveiraM., NakanoK.Comparison of laser epithelial keratomileusis with and without mitomycin C for wavefront customized surface ablations. J Refract Surg2007; 23(Suppl): S1021–8.
39.
de Benito-LlopisL., TeusM.A., Sanchez-PinaJ.M., FuentesI.Stability of laser epithelial keratomileusis with and without mitomycin C performed to correct myopia in thin corneas: a 15-month follow-up. Am J Ophthalmol2008; 145: 807–12.
40.
AydinB., CagilN., ErdoganS., ErdurmusM., HasiripiH.Effectiveness of laser-assisted subepithelial keratectomy without mitomycin-C for the treatment of high myopia. J Cataract Refract Surg2008; 34: 1280–7.
41.
AvisarR., AvisarI., BaharI., WeinbergerD.Effect of mitomycin C in pterygium surgery on corneal endothelium. Cornea2008; 27: 559–61.
42.
DiakonisV.F., PallikarisA., KymionisG.D., MarkomanolakisM.M.Alterations in endothelial cell density after photorefractive keratectomy with adjuvant mitomycin. Am J Ophthalmol2007; 144: 99–103.
43.
GoldsberryD.H., EpsteinR.J., MajmudarP.A.. Effect of mitomycin C on the corneal endothelium when used for corneal subepithelial haze prophylaxis following photorefractive keratectomy. J Refract Surg2007; 23: 724–7.
44.
ZhaoL.Q., WeiR.L., MaX.Y., ZhuH.Effect of intraoperative mitomycin-c on healthy corneal endothelium after laser-assisted subepithelial keratectomy. J Cataract Refract Surg2008; 34: 1715–9.
